TMEM176B: A Potential Drug Target and Biomarker (G28959)

Target Name: TMEM176B

NCBI ID: G28959

TMEM176B

TMEM176B: A Potential Drug Target and Biomarker

TMEM176B is a protein that falls into the family of evolutionarily conserved TMEM (Tmem) proteins, which are found in various organisms including bacteria, archaea, and eukaryotes. TMEM proteins have been identified as potential drug targets due to their unique structure and the involvement of various cellular processes, including metabolism, stress response, and DNA replication. In this article, we will explore the potential of TMEM176B as a drug target and biomarker.

Structure and Function

TMEM176B is a 21 kDa protein that is expressed in various tissues of the human body, including the brain, heart, and gastrointestinal tract. It is characterized by a unique structure that consists of a long amino acid sequence, a short alpha-helices, and a long terminal extension. The protein has a pre-伪-helices extension that is rich in charged and polar amino acids, including Asp, Glu, and Lys. This feature is unique and differentiates TMEM176B from other proteins.

TMEM176B is involved in various cellular processes, including metabolism, stress response, and DNA replication. It is a key protein in the detoxification of xenobiotics, which are harmful substances that can cause cellular stress. TMEM176B is also involved in the regulation of DNA replication, which is critical for the growth and development of cells.

Due to its involvement in these critical cellular processes, TMEM176B has been identified as a potential drug target. The use of small molecules, such as drugs, to inhibit TMEM176B's activity can be a promising approach to treating various diseases.

TMEM176B as a Biomarker

In addition to its potential as a drug target, TMEM176B has also been identified as a potential biomarker for various diseases. The detection and quantification of TMEM176B can be used to monitor the effectiveness of certain treatments and to identify potential biomarkers for diseases.

For example, TMEM176B has been used as a biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. In cancer, TMEM176B has been shown to be involved in the regulation of cell growth, which can be used as a potential biomarker for the diagnosis and treatment of cancer. In neurodegenerative diseases, TMEM176B has been shown to be involved in the regulation of protein homeostasis, which can be used as a potential biomarker for the diagnosis and treatment of neurodegenerative diseases. In cardiovascular diseases, TMEM176B has been shown to be involved in the regulation of cell signaling, which can be used as a potential biomarker for the diagnosis and treatment of cardiovascular diseases.

TMEM176B as a Drug Target

The unique structure of TMEM176B and its involvement in various cellular processes make it an attractive target for drug development. The use of small molecules, such as drugs, to inhibit TMEM176B's activity can be a promising approach to treating various diseases.

One of the potential benefits of targeting TMEM176B is its involvement in the detoxification of xenobiotics, which are harmful substances that can cause cellular stress. TMEM176B has been shown to be involved in the detoxification of xenobiotics, which can make it an attractive target for drugs that are used to treat xenobiotics-induced cellular stress.

Another potential benefit of targeting TMEM176B is its involvement in the regulation of DNA replication, which is critical for the growth and development of cells. TMEM176B has

Protein Name: Transmembrane Protein 176B

Functions: May play a role in the process of maturation of dendritic cells. Required for the development of cerebellar granule cells (By similarity)

The "TMEM176B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM176B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets